Arrowhead Acquires Novartis’ RNAi Research and Development Portfolio
Go back to Arrowhead Acquires Novartis’ RNAi Research and Development Portfolio| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 74.11 -2.29 (3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.40 | 52 Week High | $8.22 | |||
| Open | $74.82 | 52 Week Low | $3.07 | |||
| Day High | $74.89 | P/E | N/A | |||
| Day Low | $72.66 | EPS | $-1.30 | |||
| Volume | 2,481,508 | |||||
